Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification

BACKGROUND: Flow diverters offer a promising treatment for cerebral aneurysms. However, they have associated thromboembolic risks, mandating chronic dual antiplatelet therapy (DAPT). Shield Technology is a phosphorylcholine surface modification of the Pipeline Embolization Device (PED) flow diverter...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Neurointerv Surg
Hlavní autoři: Hagen, Matthew W, Girdhar, Gaurav, Wainwright, John, Hinds, Monica T
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2017
Témata:
Basic Science
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5629931/
https://ncbi.nlm.nih.gov/pubmed/27799376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/neurintsurg-2016-012612
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky